About Capecitabine
            
            Class: | Antimetabolite, Pyrimidine analog  
Use: | Treatment of metastatic breast cancer, colorectal cancer, and other solid tumors; often used as adjuvant therapy  
Adult dose: | 1250 mg/m² orally twice daily for 14 days followed by a 7-day rest period (for a total of 21-day cycle); dosing may vary based on specific cancer type and patient tolerance  
Pediatric dose: | Safety and efficacy not established; use is not recommended in pediatric populations  
Side effects: | Hand-foot syndrome, nau
         
        
            
                
                
                    
                        Drug Class
                    
                    Antimetabolite, Pyrimidine analog
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of metastatic breast cancer, colorectal cancer, and other solid tumors; often used as adjuvant therapy
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from moisture and light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Reliance Life Sciences Private Limited, India
                    
                    
                    Package Size
                    10's x 12 tabs
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 746.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        1250 mg/m² orally twice daily for 14 days followed by a 7-day rest period (for a total of 21-day cycle); dosing may vary based on specific cancer type and patient tolerance
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established; use is not recommended in pediatric populations
                    
                 
                
                
                    
                        Side Effects
                    
                    Hand-foot syndrome, nausea, vomiting, diarrhea, fatigue, stomatitis, myelosuppression, and increased liver enzymes
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to capecitabine or any of its components; severe renal impairment (CrCl < 30 mL/min); concomitant use with sorivudine or its analogs
         
        
        
            
                Important Warnings
            
            Risk of severe skin reactions, myelosuppression, and gastrointestinal toxicity; monitor for signs of dehydration and renal impairment; caution in patients with hepatic impairment or those receiving anticoagulants
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.